Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bella Ungar

Showing results (21-30 of 87) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Gastroenterology|August 22, 2020
Predictors of mortality in inflammatory bowel disease patients treated for pneumoniaOffir Ukashi, Yifatch Barash, Michael J Segel, et al.
European Journal of Gastroenterology & Hepatology|January 13, 2021
Qualitative sonographic assessment of transmural ileal inflammation in Crohn's disease: a comparison with MRI activity scoreMoran Livne, Michal Mariene Amitai, Eyal Klang, et al.
Journal of Clinical Medicine|September 28, 2021
Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional StudyIdo Veisman, Oranit Barzilay, Liora Bruckmayer, et al.
Therapeutic Advances in Gastroenterology|October 28, 2021
Machine learning for prediction of intra-abdominal abscesses in patients with Crohn's disease visiting the emergency departmentAsaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, et al.
Journal of Crohn'S & Colitis|May 9, 2024
Pan-Enteric Crohn's Capsule [Eliakim] Score Reliability and Responsiveness to Change in Active Crohn's DiseaseOffir Ukashi, Adi Lahat, Bella Ungar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2026
Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysisYaron Cohen, Andreas Münch, Asaf Levartovsky, et al.
Inflammatory Bowel Diseases|April 28, 2016
Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel AssayRoni Weisshof, Bella Ungar, Alexandra Blatt, et al.
Annals of Gastroenterology|October 13, 2025
Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapyAhmad Albshesh, Pesah Melnik, Arad Dotan, et al.
Journal of Clinical Medicine|November 18, 2020
Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective StudyHussein Mahajna, Yiftach Barash, Bella Ungar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 17, 2019
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidenceTal Engel, Diana E Yung, Christopher Ma, et al.
Pageof 9

Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Gastroenterology|August 22, 2020
Predictors of mortality in inflammatory bowel disease patients treated for pneumoniaOffir Ukashi, Yifatch Barash, Michael J Segel, et al.
European Journal of Gastroenterology & Hepatology|January 13, 2021
Qualitative sonographic assessment of transmural ileal inflammation in Crohn's disease: a comparison with MRI activity scoreMoran Livne, Michal Mariene Amitai, Eyal Klang, et al.
Journal of Clinical Medicine|September 28, 2021
Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional StudyIdo Veisman, Oranit Barzilay, Liora Bruckmayer, et al.
Therapeutic Advances in Gastroenterology|October 28, 2021
Machine learning for prediction of intra-abdominal abscesses in patients with Crohn's disease visiting the emergency departmentAsaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, et al.
Journal of Crohn'S & Colitis|May 9, 2024
Pan-Enteric Crohn's Capsule [Eliakim] Score Reliability and Responsiveness to Change in Active Crohn's DiseaseOffir Ukashi, Adi Lahat, Bella Ungar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 18, 2026
Immunomodulatory therapies and emerging drug associations with microscopic colitis: A global pharmacovigilance analysisYaron Cohen, Andreas Münch, Asaf Levartovsky, et al.
Inflammatory Bowel Diseases|April 28, 2016
Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel AssayRoni Weisshof, Bella Ungar, Alexandra Blatt, et al.
Annals of Gastroenterology|October 13, 2025
Accuracy of intestinal ultrasonography in the evaluation of patients with moderate-to-severe ulcerative colitis starting infliximab therapyAhmad Albshesh, Pesah Melnik, Arad Dotan, et al.
Journal of Clinical Medicine|November 18, 2020
Prediction of Recurrent Emergency Department Visits among Patients with Crohn's Disease: A Retrospective StudyHussein Mahajna, Yiftach Barash, Bella Ungar, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 17, 2019
Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidenceTal Engel, Diana E Yung, Christopher Ma, et al.
Pageof 9